Maria F. Abad-Cano

Madrid, MD 28006, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Valproic Acid Stimulates Release of Ca2+ from InsP3-Sensitive Ca2+ Stores.

Valproic Acid Stimulates Release of Ca2+ from InsP3-Sensitive Ca2+ Stores.

Journal: International journal of molecular sciences

Published: December 16, 2025

Protocol for isolating and culturing human monocytes from peripheral blood and measuring intracellular calcium dynamics using Fura-2.

Protocol for isolating and culturing human monocytes from peripheral blood and measuring intracellular calcium dynamics using Fura-2.

Journal: STAR protocols

Published: December 01, 2025

The CALHM1 blocker CGP37157 increases seizure severity during status epilepticus in adult mice.

The CALHM1 blocker CGP37157 increases seizure severity during status epilepticus in adult mice.

Journal: Purinergic signalling

Published: April 07, 2025

Cytotoxicity Models in Chromaffin Cells to Evaluate Neuroprotective Compounds.

Cytotoxicity Models in Chromaffin Cells to Evaluate Neuroprotective Compounds.

Journal: Methods in molecular biology (Clifton, N.J.)

Published: October 07, 2022

Intracellular calcium and inflammatory markers, mediated by purinergic stimulation, are differentially regulated in monocytes of patients with major depressive disorder.

Intracellular calcium and inflammatory markers, mediated by purinergic stimulation, are differentially regulated in monocytes of patients with major depressive disorder.

Journal: Neuroscience letters

Published: March 10, 2021

Molecular and Pharmacological Modulation of CALHM1 Promote Neuroprotection against Oxygen and Glucose Deprivation in a Model of Hippocampal Slices.

Molecular and Pharmacological Modulation of CALHM1 Promote Neuroprotection against Oxygen and Glucose Deprivation in a Model of Hippocampal Slices.

Journal: Cells

Published: January 22, 2020

The purinergic P2X7 receptor as a potential drug target to combat neuroinflammation in neurodegenerative diseases.

The purinergic P2X7 receptor as a potential drug target to combat neuroinflammation in neurodegenerative diseases.

Journal: Medicinal research reviews

Published: October 07, 2019

The APPswe/PS1A246E mutations in an astrocytic cell line leads to increased vulnerability to oxygen and glucose deprivation, Ca2+ dysregulation, and mitochondrial abnormalities.

The APPswe/PS1A246E mutations in an astrocytic cell line leads to increased vulnerability to oxygen and glucose deprivation, Ca2+ dysregulation, and mitochondrial abnormalities.

Journal: Journal of neurochemistry

Published: July 22, 2017

Chromaffin cells as a model to evaluate mechanisms of cell death and neuroprotective compounds.

Chromaffin cells as a model to evaluate mechanisms of cell death and neuroprotective compounds.

Journal: Pflugers Archiv : European journal of physiology

Published: June 27, 2017

ITH33/IQM9.21 provides neuroprotection in a novel ALS model based on TDP-43 and Na+/Ca2+ overload induced by VTD.

ITH33/IQM9.21 provides neuroprotection in a novel ALS model based on TDP-43 and Na+/Ca2+ overload induced by VTD.

Journal: Neuroscience letters

Published: July 05, 2016

CALHM1 and its polymorphism P86L differentially control Ca²⁺homeostasis, mitogen-activated protein kinase signaling, and cell vulnerability upon exposure to amyloid β.

CALHM1 and its polymorphism P86L differentially control Ca²⁺homeostasis, mitogen-activated protein kinase signaling, and cell vulnerability upon exposure to amyloid β.

Journal: Aging cell

Published: August 20, 2015

Neuroprotective Effect of the Novel Compound ITH33/IQM9.21 Against Oxidative Stress and Na(+) and Ca(2+) Overload in Motor Neuron-like NSC-34 Cells.

Neuroprotective Effect of the Novel Compound ITH33/IQM9.21 Against Oxidative Stress and Na(+) and Ca(2+) Overload in Motor Neuron-like NSC-34 Cells.

Journal: Neurotoxicity research

Published: August 18, 2015

Showing 1-12 of 18

Last Updated: 09/26/2026